Partner
Milson Yu
About Milson
Milson represents private and public companies and investment banks in various capital markets and corporate transactions, including initial public offerings, follow-on and secondary offerings, debt offerings and SPAC mergers. Milson also counsels public companies on a full range of corporate and securities matters, including SEC reporting obligations and corporate governance.
Milson’s recent representative transactions include advising:
- Instacart on its $660 million IPO
- Confluent on its $828 million IPO and its $1.1 billion Rule 144A convertible notes offering
- 1Life Healthcare (One Medical) on its:
- $281.8 million IPO
- $275 million Rule 144A convertible notes offering
- $2.1 billion all-stock acquisition of Iora Health
- Thayer Ventures on its $1.1 billion deSPAC business combination with Inspirato
- Opthea on its $128 million IPO
- Docebo on its $165.6 million IPO and multiple secondary offerings
- Absolute Software on its $69 million IPO and its $340 million cash acquisition of NetMotion
- The underwriters on AssetMark’s $316 million IPO
- NVIDIA on registered notes offerings raising $10 billion in aggregate
- Jazz Pharmaceuticals on its $1 billion Rule 144A exchangeable notes offering
Education
-
Cornell Law School
JD, cum laude, 2013 -
Samuel Curtis Johnson Graduate School of Management, Cornell University
MBA, with distinction, 2013 -
Georgia Institute of Technology
BSM, magna cum laude, 2010
Rankings and accolades
Chambers USA: Capital Markets: Debt & Equity: Western United States – Nationwide (2024 – 2025)
Chambers USA: Up and Coming for Capital Markets: Debt & Equity – California (2024 – 2025)
Law360: Rising Stars of 2024
The Legal 500 US: Capital Markets: Equity Offerings (2025)